Urigen Pharmaceuticals, Inc. Contracts & Agreements
77 Contracts & Agreements
- Business Finance (29 contracts)
- Business Operations (2)
- Human Resources (8)
- Intellectual Property (5)
- Mergers & Acquisitions (4)
- Real Estate (2)
- Uncategorized (27)
- URIGEN PHARMACEUTICALS, INC. 2014 LONG-TERM INCENTIVE PLAN * * * * * (Filed With SEC on February 11, 2015)
- EXCHANGEAND WAIVER AGREEMENT Datedas of April 25, 2014 byand among URIGENPHARMACEUTICALS, INC., PLATINUM-MONTAURLIFE SCIENCES, LLC AND THEOTHER LENDERS NAMED HEREIN (Filed With SEC on February 11, 2015)
- SECURITY AGREEMENT (Filed With SEC on February 11, 2015)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 11, 2015)
- GUARANTY (Filed With SEC on February 11, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on February 11, 2015)
- EMPLOYMENT AGREEMENT (Filed With SEC on February 11, 2015)
- LICENSE AGREEMENT (Filed With SEC on February 11, 2015)
- FORMULATION AND USE AGREEMENT (Filed With SEC on February 11, 2015)
- Consulting Agreement between the Company and BioEnsemble, Ltd. dated as of July 1, 2010 (Filed With SEC on August 10, 2012)
- Amend and Restated Consulting Agreement between the Company and BioEnsemble, Ltd. dated as of June 30, 2011 (Filed With SEC on August 10, 2012)
- Waiver Letter dated March 14, 2012 from Platinum-Montaur Life Sciences, LLC (Filed With SEC on August 10, 2012)
- FOURTH AMENDMENT TO TRANSACTION DOCUMENTS (Filed With SEC on January 10, 2012)
- URIGEN PHARMACEUTICALS, INC. Senior Convertible Promissory Note due September 3, 2013 (Filed With SEC on January 10, 2012)
- SERIES 2011 WARRANT TO PURCHASE SHARES OF COMMON STOCK OF URIGEN PHARMACEUTICALS, INC. Expires March 3, 2016 (Filed With SEC on January 10, 2012)
- FIFTH AMENDMENT TO TRANSACTION DOCUMENTS (Filed With SEC on January 10, 2012)
- URIGEN PHARMACEUTICALS, INC. Senior Convertible Promissory Note due October 5, 2013 No. 3$300,000Dated:October 5, 2011 (Filed With SEC on January 10, 2012)
- SERIES 2011 WARRANT TO PURCHASE SHARES OF COMMON STOCK OF URIGEN PHARMACEUTICALS, INC. Expires October 5, 2016 (Filed With SEC on January 10, 2012)
- THIRD AMENDMENT TO TRANSACTION DOCUMENTS (Filed With SEC on May 4, 2010)
- Delaware PAGE 1 The First State (Filed With SEC on May 4, 2010)
- SERIES B WARRANT TO PURCHASE SHARES OF COMMON STOCK OF URIGEN PHARMACEUTICALS, INC. Expires April 19, 2015 (Filed With SEC on May 4, 2010)
- CONSULTINGAGREEMENT (Filed With SEC on December 21, 2009)
- AMENDMENTTO SENIORSECURED CONVERTIBLE PROMISSORY NOTES (Filed With SEC on October 29, 2009)
- DEBTSETTLEMENT AGREEMENT (Filed With SEC on October 28, 2009)
- AMENDMENT NO. 3 TO THE (Filed With SEC on August 26, 2009)
- SECOND AMENDMENT TO TRANSACTION DOCUMENTS (Filed With SEC on August 20, 2009)
- URIGEN PHARMACEUTICALS, INC. Senior Secured Convertible Promissory Note due October 9, 2009 No. 3$202,500 (Filed With SEC on August 20, 2009)
- Exhibit10.1 AMENDMENTTO TRANSACTION DOCUMENTS (Filed With SEC on April 29, 2009)
- URIGENPHARMACEUTICALS, INC. SeniorSecured Convertible Promissory Note dueOctober 9, 2009 No. 2 $40,000 Dated:April 28, 2009 (Filed With SEC on April 29, 2009)
- NOTEPURCHASE AGREEMENT Datedas of January 9, 2009 byand among URIGENPHARMACEUTICALS, INC. and THEPURCHASERS LISTED ON EXHIBIT A (Filed With SEC on January 15, 2009)
- URIGENPHARMACEUTICALS, INC. SeniorSecured Convertible Promissory Note dueOctober 9, 2009 No. 1 $257,000 (Filed With SEC on January 15, 2009)
- Exhibit10.3 SECURITYAGREEMENT (Filed With SEC on January 15, 2009)
- PATENT,TRADEMARK AND COPYRIGHT SECURITYAGREEMENT (Filed With SEC on January 15, 2009)
- GUARANTY (Filed With SEC on January 15, 2009)
- AMENDMENTNO. 2 TO THE (Filed With SEC on December 29, 2008)
- EMPLOYMENTAGREEMENT (Filed With SEC on August 11, 2008)
- EMPLOYMENTAGREEMENT (Filed With SEC on August 11, 2008)
- DEVELOPMENT AND LICENSE AGREEMENT between M & P Patent AG, c/o Fundationsanstalt, Heiligkreuz 6, 9490 Vaduz, Liechtenstein (Filed With SEC on November 27, 2007)
- EMPLOYMENT AGREEMENT (Filed With SEC on October 10, 2007)
- AMENDMENT (Filed With SEC on August 10, 2007)
- DelawarePAGE 1 ________________________________ The First State (Filed With SEC on August 6, 2007)
- SERIES A WARRANT TO PURCHASE SHARES OF COMMON STOCK OF URIGEN PHARMACEUTICALS, INC. Expires August 1, 2012 No.: W-A -001 Number of Shares:14,000,000 Date of Issuance: August 1,... (Filed With SEC on August 6, 2007)
- SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT Dated as of July 31, 2007 between URIGEN PHARMACEUTICALS, INC. and PLATINUM-MONTAUR LIFE SCIENCES, LLC (Filed With SEC on August 6, 2007)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 6, 2007)
- EXECUTIVE EMPLOYMENT AGREEMENT URIGEN HOLDINGS INC. PRIVATE AND CONFIDENTIAL As of May 1, 2006 (Filed With SEC on July 19, 2007)
- THIRDAMENDMENT TO AGREEMENT AND PLAN OF MERGER (Filed With SEC on May 15, 2007)
- EXCLUSIVE LICENSEAGREEMENT (Filed With SEC on April 18, 2007)
- SECOND AMENDMENT TO AGREEMENTAND PLAN OF MERGER (Filed With SEC on March 28, 2007)
- WAIVER, CONSENT AND AMENDMENT TO AGREEMENT AND PLAN OF MERGER (Filed With SEC on February 7, 2007)
- AMENDMENTNO. 1 to the AssetPurchase Agreement by and betweenMedarex, Inc. and Valentis, Inc. (Filed With SEC on February 1, 2007)
- NON-EXCLUSIVELICENSE AGREEMENT (Filed With SEC on January 11, 2007)
- AGREEMENTFOR TERMINATION OF LEASE AND VOLUNTARY SURRENDER OF PREMISES (Filed With SEC on November 22, 2006)
- TECHNOLOGY TRANSFERAGREEMENT BETWEEN VALENTIS, INC. AND VICAL INCORPORATED DATED AS OF OCTOBER 24,2006 (Filed With SEC on November 2, 2006)
- LICENSE AGREEMENT (Filed With SEC on November 2, 2006)
- ASSET TRANSFER AGREEMENT BETWEEN VALENTIS, INC. AND BIOLITEC, INC. DATED AS OF OCTOBER 26,2006 (Filed With SEC on November 1, 2006)
- ASSET PURCHASE AGREEMENT (Filed With SEC on November 1, 2006)
- ASSET TRANSFER AGREEMENT BETWEEN VALENTIS, INC. AND JUVARIS BIOTHERAPEUTICS, INC. DATED AS OF OCTOBER 27, 2006 (Filed With SEC on November 1, 2006)
- LICENSE AGREEMENT (Filed With SEC on November 1, 2006)
- TECHNOLOGY TRANSFERAGREEMENT BETWEEN VALENTIS, INC. AND GENETRONICS BIOMEDICALCORPORATION DATED AS OF OCTOBER 16,2006 (Filed With SEC on October 19, 2006)
- AGREEMENT AND PLANOF MERGER By and Among VALENTIS, INC., asParent, VALENTIS HOLDINGS,INC., as Merger Sub and URIGEN, N. A., INC. (Filed With SEC on October 5, 2006)
- VOTING AGREEMENT (Filed With SEC on October 5, 2006)
- VOTING AGREEMENT (Filed With SEC on October 5, 2006)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 22, 2006)
- VALENTIS,INC. WARRANT (Filed With SEC on March 22, 2006)
- REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on March 22, 2006)
- FOURTH AMENDMENT TO LEASE (Filed With SEC on September 26, 2005)
- VALENTIS, INC. STOCK BONUS AWARDAGREEMENT (Filed With SEC on July 1, 2005)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on June 27, 2005)
- REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on June 27, 2005)
- VALENTIS,INC. WARRANT (Filed With SEC on June 27, 2005)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on June 14, 2004)
- VALENTIS, INC. WARRANT (Filed With SEC on June 14, 2004)
- REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on June 14, 2004)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 31, 2003)
- VALENTIS, INC. WARRANT (Filed With SEC on December 31, 2003)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 31, 2003)
- LICENSE AND OPTION AGREEMENT (Filed With SEC on February 14, 2003)
